{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:55:10Z","timestamp":1790949310537,"version":"4.1.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ihj.2022.11.011","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T21:54:58Z","timestamp":1669672498000},"page":"431-440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Revisiting secondary prevention in coronary heart disease"],"prefix":"10.1016","volume":"74","author":[{"given":"Alben","family":"Sigamani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ihj.2022.11.011_bib1","doi-asserted-by":"crossref","DOI":"10.2174\/1573399816666201006144606","article-title":"Epidemiology of ischemic heart disease and diabetes in South Asia: an overview of the twin epidemic","volume":"17","author":"Gupta","year":"2021","journal-title":"Curr Diabetes Rev"},{"issue":"3","key":"10.1016\/j.ihj.2022.11.011_bib2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ahj.2010.10.042","article-title":"Cardiovascular research in India: a perspective","volume":"161","author":"Vamadevan","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.ihj.2022.11.011_bib3","series-title":"Fuster & Hurst's: The Heart","first-page":"511","article-title":"Location and level of care, education, availability of medicines and cardiovascular mortality","author":"Gupta","year":"2022"},{"issue":"22","key":"10.1016\/j.ihj.2022.11.011_bib4","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/CIR.0b013e318235eb4d","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American heart association and American College of Cardiology foundation","volume":"124","author":"Smith","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2022.11.011_bib5","doi-asserted-by":"crossref","first-page":"S419","DOI":"10.1016\/j.ihj.2018.05.002","article-title":"Low quality cardiovascular care is important coronary risk factor in India","volume":"70","author":"Gupta","year":"2018","journal-title":"Indian Heart J"},{"issue":"10","key":"10.1016\/j.ihj.2022.11.011_bib6","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.jacc.2006.04.026","article-title":"AHA\/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute","volume":"47","author":"Smith","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.ihj.2022.11.011_bib7","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/CIRCULATIONAHA.119.044282","article-title":"Secondary prevention for atherosclerotic cardiovascular disease: comparing recent US and European guidelines on dyslipidemia","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"issue":"34","key":"10.1016\/j.ihj.2022.11.011_bib8","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2022.11.011_bib9","series-title":"ESC Textbook of Cardiovascular Medicine","first-page":"1209","article-title":"Acute coronary syndromes","author":"James","year":"2019"},{"key":"10.1016\/j.ihj.2022.11.011_bib10","series-title":"Fuster & Hurst's: The Heart","first-page":"655","article-title":"Chronic coronary syndromes","author":"Bangalore","year":"2022"},{"issue":"1","key":"10.1016\/j.ihj.2022.11.011_bib89","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5334\/gh.783","article-title":"Cardiac Rehabilitation in India: Results from the International Council of Cardiovascular Prevention and Rehabilitation\u2019s Global Audit of Cardiac Rehabilitation","volume":"15","author":"Babu","year":"2020","journal-title":"Global Heart"},{"issue":"11","key":"10.1016\/j.ihj.2022.11.011_bib12","first-page":"820","article-title":"WHO study on prevention of REcurrences of myocardial infarction and StrokE (WHO-premise)","volume":"83","author":"Mendis","year":"2005","journal-title":"Bull World Health Organ"},{"issue":"9667","key":"10.1016\/j.ihj.2022.11.011_bib13","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(09)60330-5","article-title":"Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries","volume":"373","author":"Kotseva","year":"2009","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ihj.2022.11.011_bib14","article-title":"Association of neighborhood socioeconomic context with participation in cardiac rehabilitation","volume":"6","author":"Bachmann","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"9798","key":"10.1016\/j.ihj.2022.11.011_bib15","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(11)61215-4","article-title":"Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey","volume":"378","author":"Yusuf","year":"2011","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ihj.2022.11.011_bib16","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1177\/2047487314540386","article-title":"Socioeconomic factors and use of secondary preventive therapies for cardiovascular diseases in South Asia: the PURE study","volume":"22","author":"Gupta","year":"2015","journal-title":"Eur J Prev Cardiol"},{"issue":"2","key":"10.1016\/j.ihj.2022.11.011_bib17","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijcard.2008.03.047","article-title":"Secondary prevention of coronary artery disease in urban Indian primary care","volume":"135","author":"Gupta","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ihj.2022.11.011_bib11","first-page":"1007","article-title":"Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India","volume":"5","author":"Sharma","year":"2009","journal-title":"Vasc Health Risk Manag"},{"issue":"4","key":"10.1016\/j.ihj.2022.11.011_bib18","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ahj.2008.12.009","volume":"157","author":"Niu","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.ihj.2022.11.011_bib19","series-title":"Harrison's Principles of Internal Medicine","first-page":"1872","article-title":"ST segment elevation myocardial infarction","author":"Antman","year":"2018"},{"issue":"10199","key":"10.1016\/j.ihj.2022.11.011_bib20","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(19)31893-8","article-title":"Primary prevention of ischaemic heart disease: populations, individuals, and health professionals","volume":"394","author":"Gupta","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ihj.2022.11.011_bib21","first-page":"CD012786","article-title":"Exercise-based cardiac rehabilitation for adults with stable angina","volume":"2","author":"Long","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.ihj.2022.11.011_bib90","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.28720","article-title":"Comparison of Home-Based vs Center-Based Cardiac Rehabilitation in Hospitalization, Medication Adherence, and Risk Factor Control Among Patients With Cardiovascular Disease","volume":"5","author":"Nkonde-Price","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ihj.2022.11.011_bib22","series-title":"Dietary Issues in Coronary Heart Disease Prevention. Reference Module in Food Science","author":"Gupta","year":"2022"},{"issue":"20","key":"10.1016\/j.ihj.2022.11.011_bib23","doi-asserted-by":"crossref","first-page":"7488","DOI":"10.3390\/ijerph17207488","article-title":"The promotion of eating behaviour change through digital interventions","volume":"17","author":"Chen","year":"2020","journal-title":"Int J Environ Res Publ Health"},{"issue":"1","key":"10.1016\/j.ihj.2022.11.011_bib24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1056\/NEJMra1308383","article-title":"Global effects of smoking, of quitting, and of taxing tobacco","volume":"370","author":"Jha","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ihj.2022.11.011_bib25","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.3849","article-title":"Association of habitual alcohol intake with risk of cardiovascular disease","volume":"5","author":"Biddinger","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ihj.2022.11.011_bib26","series-title":"Medscape","article-title":"Primary and secondary prevention of coronary artery disease","author":"Mohamad","year":"2021"},{"issue":"5","key":"10.1016\/j.ihj.2022.11.011_bib27","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.pcad.2013.11.001","article-title":"Cardiac rehabilitation in India","volume":"56","author":"Madan","year":"2014","journal-title":"Prog Cardiovasc Dis"},{"issue":"1","key":"10.1016\/j.ihj.2022.11.011_bib28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jacc.2019.03.008","article-title":"Home-based cardiac rehabilitation: a scientific statement from the American association of cardiovascular and pulmonary rehabilitation, the American heart association, and the American College of Cardiology","volume":"74","author":"Thomas","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.ihj.2022.11.011_bib29","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jacc.2009.08.017","article-title":"A\u00a0meta-analysis of remote monitoring of heart failure patients","volume":"54","author":"Klersy","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2022.11.011_bib30","first-page":"114","article-title":"Decrease cardiovascular risks in elderly patients of coronary artery disease","volume":"3","author":"Panwar","year":"2005","journal-title":"J\u00a0Indian Acad Geosci"},{"key":"10.1016\/j.ihj.2022.11.011_bib31","series-title":"Advances in Statin Therapy & beyond in CVD (ASTC): A Textbook of Cardiology","first-page":"50","article-title":"Controversies to consensus in classification of hyperlipidemias and importance of statins","author":"Gupta","year":"2022"},{"issue":"20","key":"10.1016\/j.ihj.2022.11.011_bib32","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.ihj.2022.11.011_bib33","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"Collet","year":"2020","journal-title":"Eur Heart J"},{"issue":"18","key":"10.1016\/j.ihj.2022.11.011_bib34","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMoa2108749","article-title":"Dual antiplatelet therapy after PCI in patients at high bleeding risk","volume":"385","author":"Valgimigli","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.ihj.2022.11.011_bib35","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJMoa1908973","article-title":"Ticagrelor or prasugrel in patients with acute coronary syndromes","volume":"381","author":"Schupke","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.ihj.2022.11.011_bib36","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1056\/NEJMoa1908419","article-title":"Ticagrelor with or without aspirin in high-risk patients after PCI","volume":"381","author":"Mehran","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ihj.2022.11.011_bib37","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/CIRCULATIONAHA.120.046251","article-title":"The safety and efficacy of aspirin discontinuation on a background of a P2Y12 inhibitor in patients after percutaneous coronary intervention","volume":"142","author":"O'Donoghue","year":"2020","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.ihj.2022.11.011_bib38","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1817083","article-title":"Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation","volume":"380","author":"Lopes","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"10206","key":"10.1016\/j.ihj.2022.11.011_bib39","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(19)31872-0","article-title":"Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial","volume":"394","author":"Vranckx","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ihj.2022.11.011_bib40","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jacc.2016.03.599","article-title":"Management of patients with NSTE-ACS: a comparison of the recent AHA\/ACC and ESC guidelines","volume":"68","author":"Rodriguez","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2022.11.011_bib41","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ihj.2022.11.011_bib42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2019","journal-title":"Eur Heart J"},{"issue":"9493","key":"10.1016\/j.ihj.2022.11.011_bib43","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"issue":"9607","key":"10.1016\/j.ihj.2022.11.011_bib44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","article-title":"Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis","volume":"371","author":"Kearney","year":"2008","journal-title":"Lancet"},{"issue":"9976","key":"10.1016\/j.ihj.2022.11.011_bib45","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials","volume":"385","author":"Fulcher","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ihj.2022.11.011_bib46","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S2213-8587(19)30388-2","article-title":"Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327037 participants","volume":"8","author":"Wang","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"24","key":"10.1016\/j.ihj.2022.11.011_bib47","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology\/American heart association task force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ihj.2022.11.011_bib48","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacl.2020.01.006","article-title":"Proposed low-density lipoprotein cholesterol goals for secondary prevention and familial hypercholesterolemia in India with focus on PCSK9 inhibitor monoclonal antibodies: expert consensus statement from Lipid Association of India","volume":"14","author":"Puri","year":"2020","journal-title":"J\u00a0Clin Lipidol"},{"issue":"4","key":"10.1016\/j.ihj.2022.11.011_bib49","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10557-021-07147-5","article-title":"Role of bempedoic acid in clinical practice","volume":"35","author":"Ballantyne","year":"2021","journal-title":"Cardiovasc Drugs Ther"},{"issue":"18","key":"10.1016\/j.ihj.2022.11.011_bib50","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.ihj.2022.11.011_bib51","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.ihj.2022.11.011_bib52","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1016\/j.jacc.2019.08.010","article-title":"Evolocumab for early reduction of LDL cholesterol levels in patients with acute coronary syndromes (EVOPACS)","volume":"74","author":"Koskinas","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.ihj.2022.11.011_bib53","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Danesh","year":"2009","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.ihj.2022.11.011_bib54","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1161\/CIRCULATIONAHA.119.041998","article-title":"Association between triglyceride lowering and reduction of cardiovascular risk across multiple lipid-lowering therapeutic classes: a systematic review and meta-regression analysis of randomized controlled trials","volume":"140","author":"Marston","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ihj.2022.11.011_bib55","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ihj.2022.11.011_bib56","series-title":"Cardiology 2021: Lipids","first-page":"1","article-title":"Hyperlipidemias in India: are we different?","author":"Gupta","year":"2021"},{"key":"10.1016\/j.ihj.2022.11.011_bib57","series-title":"Angiotensin Converting Enzyme Inhibitors and Receptor Blockers in Acute Myocardial Infarction: Clinical Trials","author":"Reeder","year":"2022"},{"issue":"3","key":"10.1016\/j.ihj.2022.11.011_bib58","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"9386","key":"10.1016\/j.ihj.2022.11.011_bib59","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","volume":"362","author":"Fox","year":"2003","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ihj.2022.11.011_bib60","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2165\/00129784-200404060-00008","article-title":"Valsartan: a review of its use in patients with heart failure and\/or left ventricular systolic dysfunction after myocardial infarction","volume":"4","author":"Croom","year":"2004","journal-title":"Am J Cardiovasc Drugs"},{"issue":"14","key":"10.1016\/j.ihj.2022.11.011_bib61","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","article-title":"Trial of intensive blood-pressure control in older patients with hypertension","volume":"385","author":"Zhang","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ihj.2022.11.011_bib62","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/jamainternmed.2022.1657","article-title":"Time to clinical benefit of intensive blood pressure lowering in patients 60 Years and older with hypertension: a secondary analysis of randomized clinical trials","volume":"182","author":"Chen","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"10296","key":"10.1016\/j.ihj.2022.11.011_bib63","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0140-6736(21)00536-5","article-title":"SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications","volume":"398","author":"Brown","year":"2021","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.ihj.2022.11.011_bib64","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/CIRCULATIONAHA.118.038868","article-title":"Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus","volume":"139","author":"Zelniker","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2022.11.011_bib65","doi-asserted-by":"crossref","first-page":"m4573","DOI":"10.1136\/bmj.m4573","article-title":"Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials","volume":"372","author":"Palmer","year":"2021","journal-title":"BMJ"},{"issue":"21","key":"10.1016\/j.ihj.2022.11.011_bib66","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMra2115011","article-title":"Gliflozins in the management of cardiovascular disease","volume":"386","author":"Braunwald","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.ihj.2022.11.011_bib67","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.ihj.2022.11.011_bib68","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.ihj.2022.11.011_bib69","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.ihj.2022.11.011_bib70","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.ihj.2022.11.011_bib71","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1056\/NEJMra001529","article-title":"Cardiac rehabilitation and secondary prevention of coronary heart disease","volume":"345","author":"Ades","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ihj.2022.11.011_bib91","article-title":"50% adherence of patients suffering chronic conditions--where is the evidence?","author":"Mathes","year":"2012","journal-title":"Ger Med Sci"},{"issue":"15","key":"10.1016\/j.ihj.2022.11.011_bib72","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1161\/CIRCULATIONAHA.107.728402","article-title":"Cardiac rehabilitation\/secondary prevention programs: a raft for the rapids: why have we missed the boat?","volume":"116","author":"Thomas","year":"2007","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ihj.2022.11.011_bib73","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/eurheartj\/ehq297","article-title":"Strategies to improve drug adherence","volume":"32","author":"Laufs","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2022.11.011_bib74","doi-asserted-by":"crossref","unstructured":"Lear SA, Norena M, Banner D, et\u00a0al. Assessment of an interactive digital health \u201cbased self-management program to reduce hospitalizations among patients with multiple chronic diseases: a randomized clinical trial. JAMA Netw Open. 4(12): e2140591-e.","DOI":"10.1001\/jamanetworkopen.2021.40591"},{"issue":"4","key":"10.1016\/j.ihj.2022.11.011_bib75","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/hpm.3161","article-title":"Digital health and management of chronic disease: a multimodal technologies typology","volume":"36","author":"Vansimaeys","year":"2021","journal-title":"Int J Health Plann Manag"},{"key":"10.1016\/j.ihj.2022.11.011_bib76","series-title":"Digital Technology and Health: A Theoretical Framework. Digital Technology, Eating Behaviors, and Eating Disorders","first-page":"21","author":"Smahel","year":"2018"},{"key":"10.1016\/j.ihj.2022.11.011_bib77","series-title":"Diffusion of eHealth: Making Universal Health Coverage Achievable: Report of the Third Global Survey on eHealth","author":"Global","year":"2016"},{"issue":"1","key":"10.1016\/j.ihj.2022.11.011_bib78","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1017\/S0266462321000362","article-title":"Health technology assessment for digital technologies that manage chronic disease: a systematic review","volume":"37","author":"von Huben","year":"2021","journal-title":"Int J Technol Assess Health Care"},{"issue":"1","key":"10.1016\/j.ihj.2022.11.011_bib79","first-page":"41","article-title":"Mobile health technology: a novel tool in chronic disease management","volume":"2","author":"Fan","year":"2022","journal-title":"Int Med"},{"key":"10.1016\/j.ihj.2022.11.011_bib80","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.puhe.2020.05.024","article-title":"Effect of mobile applications on blood pressure control and their development in China: a systematic review and meta-analysis","volume":"185","author":"Han","year":"2020","journal-title":"Publ Health"},{"key":"10.1016\/j.ihj.2022.11.011_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijnurstu.2021.104087","article-title":"Effectiveness of technology-assisted cardiac rehabilitation: a systematic review and meta-analysis","volume":"124","author":"Chong","year":"2021","journal-title":"Int J Nurs Stud"},{"issue":"1","key":"10.1016\/j.ihj.2022.11.011_bib82","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jcjd.2021.04.003","article-title":"Effectiveness of workplace interventions to reduce the risk for type 2 diabetes: a systematic review and meta-analysis","volume":"46","author":"Fitzpatrick-Lewis","year":"2022","journal-title":"Can J Diabetes"},{"issue":"10","key":"10.1016\/j.ihj.2022.11.011_bib83","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.pec.2020.05.027","article-title":"Impact of technology-based patient education on modifiable cardiovascular risk factors of people with coronary heart disease: a systematic review","volume":"103","author":"Halldorsdottir","year":"2020","journal-title":"Patient Educ Counsel"},{"issue":"1","key":"10.1016\/j.ihj.2022.11.011_bib84","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pcd.2018.07.011","article-title":"Online patient education interventions in type 2 diabetes or cardiovascular disease: a systematic review of systematic reviews","volume":"13","author":"Woolley","year":"2019","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/j.ihj.2022.11.011_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.invent.2022.100497","article-title":"Social media interventions targeting exercise and diet behaviours in people with noncommunicable diseases (NCDs): a systematic review","volume":"27","author":"McKeon","year":"2022","journal-title":"Internet Interv"},{"key":"10.1016\/j.ihj.2022.11.011_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmedinf.2022.104737","article-title":"Strategies to promote the use of online health applications for early detection and raising awareness of chronic diseases among members of the general public: a systematic literature review","volume":"162","author":"Abqari","year":"2022","journal-title":"Int J Med Inf"},{"key":"10.1016\/j.ihj.2022.11.011_bib87","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijnurstu.2018.11.007","article-title":"The effectiveness of electronic health interventions on blood pressure control, self-care behavioural outcomes and psychosocial well-being in patients with hypertension: a systematic review and meta-analysis","volume":"92","author":"Ma","year":"2019","journal-title":"Int J Nurs Stud"},{"issue":"10","key":"10.1016\/j.ihj.2022.11.011_bib88","first-page":"S27","article-title":"What makes digital interventions effective for exercise promotion: a systematic review of reviews and meta-analysis","volume":"34","author":"Kaur","year":"2018","journal-title":"Can J Cardiol"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483222003777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483222003777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:24:23Z","timestamp":1762176263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483222003777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":91,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0019483222003777"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2022.11.011","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revisiting secondary prevention in coronary heart disease","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2022.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Cardiological Society of India. Published by Elsevier, a division of RELX India, Pvt. Ltd.","name":"copyright","label":"Copyright"}]}}